RPPanalyzer: Analysis of reverse-phase protein array data.
about
Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strainsAnalysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker DiscoveryReverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical Uselimma powers differential expression analyses for RNA-sequencing and microarray studiesRealizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.Reno: regularized non-parametric analysis of protein lysate array data.RNAi-based validation of antibodies for reverse phase protein arrays.A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS)The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathwayRecent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray Analysis.KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancerA Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS CellsClustering and Network Analysis of Reverse Phase Protein Array Data.Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer.Clinical utility of reverse phase protein array for molecular classification of breast cancer.Protein network construction using reverse phase protein array data.Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.Dual-Color, Multiplex Analysis of Protein Microarrays for Precision Medicine.Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels.Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.Microarray R-based analysis of complex lysate experiments with MIRACLE.Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.Sequential stopping for high-throughput experiments.Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885.Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer.
P2860
Q21559453-C28FC8A0-2847-4482-BB1B-486A2051E750Q28080766-4BD990E2-5DD9-42F2-9A7D-77E55B7D9115Q28083256-8A1B05B0-4C22-4F12-B4B1-0E844BA21C34Q29617988-C5E51488-B85C-4F07-8E78-26BAEF7A28CEQ33850616-AF200EF4-F9AE-4B16-8E77-5897C529C38FQ34216637-D905A4DD-A3A4-4409-AE47-F59FBD3735B0Q34500104-857C9351-678B-47CE-9558-6EC830A2F871Q34851612-F7E9C40C-67AA-4C0A-BB41-C76009A47554Q35559391-3C4C9C3D-F1C1-4E09-8C9D-7706B40C57E4Q35714211-CA9624A4-2B31-4D78-9579-AFB30E93AC27Q35998772-5F6647FF-C78C-4B6A-A449-73BB6582A7D9Q36086823-CFE1CC12-8210-48DE-8311-BA4616FBBA47Q36204429-A4B58E12-1376-4564-AEF3-7C26A97537D6Q36371264-E67CEEDC-DB3F-4554-9CF0-98C58A5615C9Q36510112-593FE67E-094D-415D-80DC-9BBE2DC1FC44Q38383140-A63FC7F6-2862-4EDB-A5EF-9C0DFA98A84CQ38708267-059CDFD7-449A-4591-94CF-C3A94DF622EAQ38900933-3E2D81B0-CD43-46B4-A0EF-14EE756EC390Q38907680-17E7B85D-865D-4541-9789-050B81A1C78FQ38963132-C2F54266-EDFF-4471-84AE-A59885425AFFQ38966416-910EEE3E-8966-4C48-A181-C21C5A15F524Q38969228-EB60EFF1-04E7-4007-9C3E-B259583BA1D0Q41081937-A3536CE6-97DD-4439-9F98-BA2AC56CC854Q41942112-D979B449-35CE-40DA-A925-08C1A3AB4E5CQ42375237-8A93642C-3CA8-452E-A6FA-2D0FD4DE9241Q42408205-36E24BD5-3323-4694-9560-9D9A6508B7DFQ42496885-08FD4884-5F86-4B49-8C7E-E09C4A23FD19Q50052167-B2FC911D-C43D-4BFF-8B43-3C5B31DFE007Q50437809-D844A7C5-02FA-4B18-A740-8F2225527999
P2860
RPPanalyzer: Analysis of reverse-phase protein array data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
RPPanalyzer: Analysis of reverse-phase protein array data.
@ast
RPPanalyzer: Analysis of reverse-phase protein array data.
@en
type
label
RPPanalyzer: Analysis of reverse-phase protein array data.
@ast
RPPanalyzer: Analysis of reverse-phase protein array data.
@en
prefLabel
RPPanalyzer: Analysis of reverse-phase protein array data.
@ast
RPPanalyzer: Analysis of reverse-phase protein array data.
@en
P2093
P356
P1433
P1476
RPPanalyzer: Analysis of reverse-phase protein array data.
@en
P2093
Heiko A Mannsperger
Stephan Gade
Tim Beissbarth
P304
P356
10.1093/BIOINFORMATICS/BTQ347
P407
P577
2010-07-15T00:00:00Z